Development and evaluation of drugs: from laboratory through licensure to market
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Boca Raton
CRC Press
2003
|
Ausgabe: | 2nd ed. |
Schlagworte: | |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xiv, 241 p. ill. 24 cm |
ISBN: | 0849314011 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV019665863 | ||
003 | DE-604 | ||
005 | 20050120 | ||
007 | t | ||
008 | 050120s2003 xxua||| |||| 00||| eng d | ||
010 | |a 2003041011 | ||
020 | |a 0849314011 |c alk. paper |9 0-8493-1401-1 | ||
035 | |a (OCoLC)51446021 | ||
035 | |a (DE-599)BVBBV019665863 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-19 | ||
050 | 0 | |a RM301.25 | |
082 | 0 | |a 615/.19 |2 21 | |
084 | |a VS 5360 |0 (DE-625)147688:253 |2 rvk | ||
100 | 1 | |a Lee, Chi-Jen |e Verfasser |4 aut | |
245 | 1 | 0 | |a Development and evaluation of drugs |b from laboratory through licensure to market |c Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu |
250 | |a 2nd ed. | ||
264 | 1 | |a Boca Raton |b CRC Press |c 2003 | |
300 | |a xiv, 241 p. |b ill. |c 24 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
650 | 7 | |a Geneesmiddelen |2 gtt | |
650 | 4 | |a Industrie pharmaceutique | |
650 | 4 | |a Médicaments - Droit - États-Unis | |
650 | 4 | |a Médicaments - Développement | |
650 | 4 | |a Médicaments - Essais cliniques | |
650 | 7 | |a Technische ontwikkeling |2 gtt | |
650 | 4 | |a aDrug development | |
650 | 4 | |a aDrugs |a xTesting | |
650 | 4 | |a aDrugs |a xLaw and legislation |a zUnited States | |
650 | 4 | |a aPharmaceutical industry | |
650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 0 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
689 | 1 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 1 | |8 2\p |5 DE-604 | |
700 | 1 | |a Lee, Lucia H. |e Verfasser |4 aut | |
700 | 1 | |a Lü, Zhengxiong |d ca. 20./21. Jh. |e Verfasser |0 (DE-588)129732575 |4 aut | |
999 | |a oai:aleph.bib-bvb.de:BVB01-012994167 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804133047225810944 |
---|---|
any_adam_object | |
author | Lee, Chi-Jen Lee, Lucia H. Lü, Zhengxiong ca. 20./21. Jh |
author_GND | (DE-588)129732575 |
author_facet | Lee, Chi-Jen Lee, Lucia H. Lü, Zhengxiong ca. 20./21. Jh |
author_role | aut aut aut |
author_sort | Lee, Chi-Jen |
author_variant | c j l cjl l h l lh lhl z l zl |
building | Verbundindex |
bvnumber | BV019665863 |
callnumber-first | R - Medicine |
callnumber-label | RM301 |
callnumber-raw | RM301.25 |
callnumber-search | RM301.25 |
callnumber-sort | RM 3301.25 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | VS 5360 |
ctrlnum | (OCoLC)51446021 (DE-599)BVBBV019665863 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
edition | 2nd ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02268nam a2200625 c 4500</leader><controlfield tag="001">BV019665863</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050120 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050120s2003 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2003041011</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0849314011</subfield><subfield code="c">alk. paper</subfield><subfield code="9">0-8493-1401-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)51446021</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019665863</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5360</subfield><subfield code="0">(DE-625)147688:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Chi-Jen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development and evaluation of drugs</subfield><subfield code="b">from laboratory through licensure to market</subfield><subfield code="c">Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">CRC Press</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 241 p.</subfield><subfield code="b">ill.</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Essais cliniques</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Technische ontwikkeling</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrugs</subfield><subfield code="a">xTesting</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aDrugs</subfield><subfield code="a">xLaw and legislation</subfield><subfield code="a">zUnited States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aPharmaceutical industry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Lucia H.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lü, Zhengxiong</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)129732575</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012994167</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
geographic | USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV019665863 |
illustrated | Illustrated |
indexdate | 2024-07-09T20:02:30Z |
institution | BVB |
isbn | 0849314011 |
language | English |
lccn | 2003041011 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012994167 |
oclc_num | 51446021 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | xiv, 241 p. ill. 24 cm |
publishDate | 2003 |
publishDateSearch | 2003 |
publishDateSort | 2003 |
publisher | CRC Press |
record_format | marc |
spelling | Lee, Chi-Jen Verfasser aut Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu 2nd ed. Boca Raton CRC Press 2003 xiv, 241 p. ill. 24 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Geneesmiddelen gtt Industrie pharmaceutique Médicaments - Droit - États-Unis Médicaments - Développement Médicaments - Essais cliniques Technische ontwikkeling gtt aDrug development aDrugs xTesting aDrugs xLaw and legislation zUnited States aPharmaceutical industry Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s 1\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 2\p DE-604 Lee, Lucia H. Verfasser aut Lü, Zhengxiong ca. 20./21. Jh. Verfasser (DE-588)129732575 aut 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Lee, Chi-Jen Lee, Lucia H. Lü, Zhengxiong ca. 20./21. Jh Development and evaluation of drugs from laboratory through licensure to market Geneesmiddelen gtt Industrie pharmaceutique Médicaments - Droit - États-Unis Médicaments - Développement Médicaments - Essais cliniques Technische ontwikkeling gtt aDrug development aDrugs xTesting aDrugs xLaw and legislation zUnited States aPharmaceutical industry Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
subject_GND | (DE-588)4127410-6 (DE-588)4003115-9 (DE-588)4143176-5 (DE-588)4078704-7 |
title | Development and evaluation of drugs from laboratory through licensure to market |
title_auth | Development and evaluation of drugs from laboratory through licensure to market |
title_exact_search | Development and evaluation of drugs from laboratory through licensure to market |
title_full | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu |
title_fullStr | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu |
title_full_unstemmed | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee, Lucia H. Lee, Cheng-Hsiung Lu |
title_short | Development and evaluation of drugs |
title_sort | development and evaluation of drugs from laboratory through licensure to market |
title_sub | from laboratory through licensure to market |
topic | Geneesmiddelen gtt Industrie pharmaceutique Médicaments - Droit - États-Unis Médicaments - Développement Médicaments - Essais cliniques Technische ontwikkeling gtt aDrug development aDrugs xTesting aDrugs xLaw and legislation zUnited States aPharmaceutical industry Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
topic_facet | Geneesmiddelen Industrie pharmaceutique Médicaments - Droit - États-Unis Médicaments - Développement Médicaments - Essais cliniques Technische ontwikkeling aDrug development aDrugs xTesting aDrugs xLaw and legislation zUnited States aPharmaceutical industry Zulassung Arzneimittel Arzneimittelentwicklung USA |
work_keys_str_mv | AT leechijen developmentandevaluationofdrugsfromlaboratorythroughlicensuretomarket AT leeluciah developmentandevaluationofdrugsfromlaboratorythroughlicensuretomarket AT luzhengxiong developmentandevaluationofdrugsfromlaboratorythroughlicensuretomarket |